Innometry Co., Ltd. (KOSDAQ:302430)
7,270.00
+340.00 (4.91%)
At close: Apr 14, 2026
Innometry Revenue
In the year 2025, Innometry had annual revenue of 38.57B KRW, down -27.23%. Innometry had revenue of 9.74B in the quarter ending December 31, 2025, with 7.12% growth.
Revenue
38.57B
Revenue Growth
-27.23%
P/S Ratio
1.87
Revenue / Employee
229.57M
Employees
168
Market Cap
71.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.57B | -14.43B | -27.23% |
| Dec 31, 2024 | 53.00B | -30.79B | -36.75% |
| Dec 31, 2023 | 83.78B | 8.07B | 10.66% |
| Dec 31, 2022 | 75.71B | 29.24B | 62.92% |
| Dec 31, 2021 | 46.47B | 25.75B | 124.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shin Steel | 352.17B |
| Orient Precision Industries | 157.14B |
| Cenit | 126.99B |
| Wysiwyg Studios | 102.00B |
| Sinil Pharmaceutical | 80.56B |
| SG&G Corporation | 47.70B |
| Zaigle | 34.70B |
| T.S. Investment | 18.91B |